QuickView for PDE4D;jsessionid=0F4ED5A3404A8DBC6D273D4A274739C6;jsessionid=14D59171A7A54167D31D5AF03DFBD7F9;jsessionid=B93B3D8FCEE0C28352D254F6A26AEB2A (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Extraocular muscle
Skeletal muscle
Jejunum
T Lymphocyte (CD8+) of peripheral blood
Saphenous vein

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhi…
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19.
Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF…
Adipose tissue lipolysis is regulated by PAQR11 via altering protein stability of phosphodiesterase …
Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosi…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for PDE4D;jsessionid=0F4ED5A3404A8DBC6D273D4A274739C6;jsessionid=14D59171A7A54167D31D5AF03DFBD7F9;jsessionid=B93B3D8FCEE0C28352D254F6A26AEB2A

Explore Clinical Trials Results